Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis
…, HW Van Es, FT Van Beek… - American journal of …, 2018 - atsjournals.org
Rationale: Quantitative computed tomographic (CT) measures of baseline disease severity
might identify patients with idiopathic pulmonary fibrosis (IPF) with an increased mortality risk. …
might identify patients with idiopathic pulmonary fibrosis (IPF) with an increased mortality risk. …
[HTML][HTML] Predicting outcomes in rheumatoid arthritis related interstitial lung disease
…, BJ Bartholmai, FT Van Beek… - European …, 2019 - Eur Respiratory Soc
The aim of this study was to compare radiology-based prediction models in rheumatoid
arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis …
arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis …
[HTML][HTML] Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis
…, ADM Vorselaars, FT van Beek… - Respiratory …, 2018 - Elsevier
Background Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNF-α)
is effective third-line therapy in severe sarcoidosis. The originator product of Infliximab, …
is effective third-line therapy in severe sarcoidosis. The originator product of Infliximab, …
First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
…, JC Grutters, FT van Beek… - BMJ open …, 2019 - bmjopenrespres.bmj.com
Introduction Routine and international comparison of clinical outcomes enabling identification
of best practices for patients with pulmonary sarcoidosis is lacking. The aim of this study …
of best practices for patients with pulmonary sarcoidosis is lacking. The aim of this study …
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis
…, HW van Es, T Moua, FT van Beek… - European …, 2019 - Eur Respiratory Soc
The advent of antifibrotic agents [1, 2] as standard of care in idiopathic pulmonary fibrosis (IPF)
requires that new non-inferiority IPF drug trials will need to identify smaller declines of …
requires that new non-inferiority IPF drug trials will need to identify smaller declines of …
A new variant in the ZCCHC8 gene: diverse clinical phenotypes and expression in the lung
…, CI de Bie, MPG Massink, FT van Beek… - ERJ Open …, 2024 - Eur Respiratory Soc
Introduction Pulmonary fibrosis is a severe disease which can be familial. A genetic cause
can only be found in ∼40% of families. Searching for shared novel genetic variants may aid …
can only be found in ∼40% of families. Searching for shared novel genetic variants may aid …
[HTML][HTML] Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes
…, LM Dijksman, FT van Beek… - ERJ Open …, 2019 - Eur Respiratory Soc
Our study presents findings on a previously developed standard set of clinical outcome data
for pulmonary sarcoidosis patients. We aimed to assess whether changes in outcome varied …
for pulmonary sarcoidosis patients. We aimed to assess whether changes in outcome varied …
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis
…, A Devaraj, HW van Es, T Moua, FT van Beek… - bioRxiv, 2018 - biorxiv.org
AIMS To evaluate computer-derived (CALIPER) CT variables against FVC change as potential
drug trials endpoints in IPF. METHODS 71 Royal Brompton Hospital (discovery cohort) …
drug trials endpoints in IPF. METHODS 71 Royal Brompton Hospital (discovery cohort) …
Idiopathic pulmonary fibrosis: New insights
…, LM van den Toorn, P Bresser, FT van Beek… - Nederlands Tijdschrift …, 2015 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease of unknown cause.
IPF has a poor prognosis with a mean survival of 2 to 5 years after diagnosis. The …
IPF has a poor prognosis with a mean survival of 2 to 5 years after diagnosis. The …
[HTML][HTML] Top navigation
…, LM van den Toorn, P Bresser, FT van Beek… - Ned Tijdschr …, 2015 - repub.eur.nl
Een 59-jarige leraar wiskunde wordt door de huisarts verwezen naar de polikliniek Longziekten
vanwege sinds een half jaar toenemende kortademigheid bij inspanning en hoesten. …
vanwege sinds een half jaar toenemende kortademigheid bij inspanning en hoesten. …